Schaefer, Michael
Zimmermann, Kurt
Enck, Paul
Funding for this research was provided by:
MSB Medical School Berlin - Hochschule für Gesundheit und Medizin GmbH
Article History
Received: 13 October 2022
Accepted: 8 May 2023
First Online: 24 May 2023
Competing interests
: MS has no competing financial interests to report, KZ was a former employee of the sponsoring company (SymbioPharm, Herborn, Germany) and PE is consultant of this company. PE is also consultant of PrecisionBiotics Ltd. (Cork Ireland).